Association of Pre‐Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer
American Journal of Hematology · 2025-11 · 100 (11) · 1993-2003
DOI: 10.1002/ajh.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 11.08.2025. Verfasst von Xinyuan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Initial Founding for High Level Talented Scholars in Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Clonal hematopoiesis of indeterminate potential (CHIP) might impair prognosis of several cancer types. Since previous studies predominantly focused on CHIP after cancer diagnosis, little is known about whether CHIP prior to cancer diagnosis predicts outcome. We performed a prospective cohort study, including 63 486 patients with cancer during 2006 to 2022 in the UK Biobank, to evaluate the association between pre‐diagnostic CHIP and survival of cancer patients. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using Cox regression models. We identified 2860 patients with cancer and pre‐diagnostic CHIP, and 60 626 cancer patients without CHIP. During a median follow‐up of 4.2 years, 1162 patients died in the CHIP group (921 cancer‐specific deaths), and 17 825 in the reference group (14 785 cancer‐specific deaths). Cancer patients with pre‐diagnostic CHIP exhibited a higher rate of overall death (HR 1.18, 95% CI: 1.11–1.25) and cancer‐specific death (HR 1.17, 95% CI: 1.09–1.25) compared with the reference group. A significant association of both overall death and cancer‐specific death was observed for myeloproliferative neoplasms, multiple myeloma, breast cancer, non‐Hodgkin lymphoma, and acute myeloid leukemia/myelodysplastic syndromes. The increased rate of both overall death and cancer‐specific death was noted for CHIP with TET2 , SRSF2 , or JAK2 mutation. These findings suggested extended clinical awareness in cancer patients with pre‐diagnostic CHIP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Institute of Health and Society, University of Oslo, Oslo, Norway.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.
- Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Tove Wästerlid, Qianwei Liu
Förderung
- Initial Founding for High Level Talented Scholars in Nanfang Hospital, Southern Medical University
Zitieren
APA
Liu, X., Adami, H. O., Wästerlid, T., Xue, H., Feychting, M., Smedby, K. E., Fang, F., & Liu, Q. (2025). Association of Pre‐Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer. American Journal of Hematology, 100(11), 1993-2003. https://doi.org/10.1002/ajh.70028
Vancouver
Liu X, Adami HO, Wästerlid T, Xue H, Feychting M, Smedby KE, et al. Association of Pre‐Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer. American Journal of Hematology. 2025;100(11):1993-2003. doi:10.1002/ajh.70028
BibTeX
@article{Liu2025,
author = {Liu, Xinyuan and Adami, Hans-Olov and Wästerlid, Tove and Xue, Huiwen and Feychting, Maria and Smedby, Karin E and Fang, Fang and Liu, Qianwei},
title = {Association of Pre‐Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer},
journal = {American Journal of Hematology},
year = {2025},
volume = {100},
number = {11},
pages = {1993--2003},
doi = {10.1002/ajh.70028}
}
EUVIMED